We read with great interest the article by Fujii et al., which investigated the effect of the Pecs 2 block and serratus plane block on persistent pain after mastectomy [1] . We would like to compliment the authors for their efforts to shine light on one of the potentially debilitating sequalae of breast surgery [2], chronic post-mastectomy pain, as well as comparing two of the newer fascial plane blocks head-tohead. However, we would like to voice our concerns regarding several elements in order to assist readers with interpretation of the results of this study. In their methods, Fujii et al. describe that they performed Pecs 2 and serratus plane blocks. However, the description of the blocks' performance is unclear and lacks details of level of block, probe position and orientation and needle direction, all important factors required to interpret the results. For example, a recent anatomical study of the Pecs blocks showed that the site of injection influences the effectiveness of the block as it determines the extent of spread, and consequently mass of local anaesthetic, reaching target nerves [3].
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Additionally, the incidence and severity of persistent postoperative pain after breast cancer surgery is driven by a number of factors [4] . It appears as though the authors have not accounted for such factors in their study, and there was no mention of exclusion or allowance for pre-operative pain.
The primary outcome of Fujii's study is the rate of pain 'worse than mild' at six postoperative months. The study, however, lacks any description on how the researchers managed confounding elements ranging from pain unrelated to the breast cancer surgery to the use of analgesics [4] . We argue therefore that both their primary outcome, as well as the power analysis, is flawed.
Furthermore, there is a lack of information on vital elements such as block duration and they used health-related utility instrument EQ-5D-3L, which is aimed at quality-adjusted life years with a much lower sensitivity to measure postoperative pain and its effect on patients than the extensively validated Brief Pain Inventory [5] or Quality-of-Life 15/40 surveys [6] .
In their Discussion, the authors claim that 'these blocks [. . .] improve persistent post-mastectomy pain'. We fundamentally disagree with this claim for two reasons. First, the source for this claim is a small pilot study and a case series. Second, the authors disregard evidence which concluded otherwise [7] .
Finally, we would encourage a more thorough discussion of the study outcome parameters. It is worthwhile discussing that at 24 h postoperatively, it is expected that pain levels would be comparable between both groups. This is because the effect of 30 ml ropivacaine 0.5% without the use of adjuncts, injected as a single shot inter-fascial plane block, would be negligible after 24 h [8] . Additionally, the authors do not discuss the fact that the rates of pain-free women were initially lower (25% vs. 48%) following serratus plane block, while the incidence of chronic pain was higher (33% vs. 10%).
There is still much to learn about inter-fascial plane blocks and how the addition of the medial and lateral pectoral nerve blockade, arguably the main difference between the two blocks in this study, affects the quality of analgesia provided. It is important, though, to ensure that data are interpreted and disseminated correctly.
B. Versyck

Clarification on chronic paina painfully persistent problem? A reply
We thank Dr Versyck et al. [1] for their thoughtful comments and reflections on our article [2] . We agree that the injection site is important for the effectiveness of both the PECS 2 and serratus plane blocks. To administer the PECS 2 block in our study, the ultrasound transducer was placed on the lateral side of the mid-clavicular line at the third rib level in the direction of the axilla. The needle was inserted 'in plane' from medial to lateral and 10 ml ropivacaine 0.5% was injected between the pectoralis muscles. Thereafter, the transducer was moved laterally to the anterior axillary line at the fourth rib level, and 20 ml ropivacaine 0.5% was injected above the serratus anterior muscle. Conversely, for the serratus plane block, the transducer was placed on the midaxillary line between the fourth and fifth ribs. The needle was inserted 'in plane' from medial to lateral and 30 ml ropivacaine 0.5% was injected between the serratus anterior and latissimus dorsi muscles. Therefore, the first injection of the PECS 2 block might not only act on the medial and lateral pectoral nerves but also on the intercostobrachial nerves and axillary nerve.
Major risk factors affecting chronic post-mastectomy pain were axillary lymph node dissection, postoperative radiation therapy, younger age and pre-operative pain. Our study included patients without pre-operative pain [2] . We assessed chronic pain of the ipsilateral arm, axilla, shoulder or chest at six postoperative months. The proportion of chronic pain cases was assessed using an adjusted odds ratio for axillary lymph node dissection and postoperative radiation therapy. Although we did not limit the use of analgesics after discharge, the PECS 2 block reduced analgesic use at 6 postoperative months; 2.5% in PECS 2 block vs. 20% in serratus plane block (p = 0.03). Based on a report by Kim et al. [3] , we evaluated comprehensive health-related quality of life (QOL) after mastectomy using EQ-5D. We agree that the Quality of Recovery-15 or -40 is also a valid patient-reported outcome questionnaire for measures of health-related QOL and the Brief Pain Inventory assesses pain intensity and pain-related physical and emotional dysfunction. However, EQ-5D has fewer questions and can easily evaluate health-related QOL.
Regarding postoperative acute analgesia, several meta-analyses have reported that PECS 2 block and serratus plane block are effective [4, 5] . However, it is uncertain which block is more effective. Although there was no difference in pain intensity at 24 h postoperatively between the two blocks, morphine consumption in the first 24 h postoperatively was higher following serratus plane block than the PECS 2 block [2] .
We demonstrated that the PECS 2 block was more effective than the serratus plane block for post-mastectomy
